NCT04263415View on ClinicalTrials.gov

The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 2, 2019

Primary Completion Date

May 8, 2020

Study Completion Date

October 31, 2021

Conditions
PCOSSemaglutideTaste, AlteredTongue Tissue TranscriptomeGastric EmptyingCentral Neural Response
Interventions
DRUG

Semaglutide

semaglutide inrun period of 4 weeks with 0.5mg/week s.c. followed by 1mg/week sc for 12 weeks

OTHER

Placebo

once-weekly injection with placebo pen for 16 weeks

Trial Locations (1)

1000

UMC Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT04263415 - The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity | Biotech Hunter | Biotech Hunter